Portfolio (Quarterly)
Guide ↗
Crestline Management, L.P.
· CIK 0001536054| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 2,210,732.0 | $42.4M | 91.74% | -600K | -21.4% | $19.20 | -2.9% |
| 2 | SANA | SANA BIOTECHNOLOGY INC | Healthcare | 755,736.0 | $2.2M | 4.70% | -465K | -38.1% | $2.88 | +6.6% |
| 3 | EGHT | 8X8 INC NEW | Technology | 990,850.0 | $1.6M | 3.56% | — | — | $1.66 | +32.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.4%
Technology
3.6%